Ascendis Pharma A/S (ASND)
NASDAQ: ASND
· Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT
Ascendis Pharma A/S Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 517.92M | 559.54M | 625.51M | 258.7M | 320.24M | 392.16M | 441.27M | 394.22M | 501.28M | 444.77M | 608.33M | 672.39M | 755.64M | 446.27M | 692.94M | 384.54M | 495.05M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | 7.28M | 14.16M | 36.88M | 84.46M | 290.69M | 311.48M | 282.77M | 223.06M | 235.8M | 165.35M | 166.09M | 169.66M |
Long-Term Investments | 40.94M | 13.57M | 16.21M | 22.76M | 24.8M | 5.69M | 8.12M | 14.11M | 21.97M | 30.42M | 47.34M | 74.63M | 121.51M | 145.91M | 115.25M | 136.48M | 156.46M |
Other Long-Term Assets | 2.66M | 2.32M | 2.2M | 63.64K | 2.13M | 2.13M | 2.14M | 2.07M | 1.98M | 1.92M | 1.9M | 1.84M | 1.82M | 1.81M | 1.71M | 1.7M | 1.78M |
Receivables | 76.82M | 177.44M | 50.35M | 80.68M | 41.09M | 35.87M | 26.79M | 20.21M | 16.12M | 11.91M | 6.66M | 4.37M | 5.81M | 2.2M | 533K | 394K | 60K |
Inventory | 293.07M | 295.61M | 265.43M | 251.2M | 232.68M | 208.93M | 189.13M | 167.92M | 150.85M | 130.67M | 103.97M | 101.32M | 92.44M | 75.41M | 55.27M | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | 27.6M | 19.9M | 23.24M | 15.49M | 18.44M | 13.72M | 14.89M | 16.18M | 16.14M | 20.99M | 20.26M | n/a | n/a |
Total Current Assets | 921.49M | 1.06B | 973.74M | 627.32M | 664.11M | 702.72M | 732.92M | 677.68M | 809.85M | 923.47M | 1.08B | 1.11B | 1.12B | 805.89M | 956.59M | 584.25M | 687.27M |
Property-Plant & Equipment | 92.45M | 98.71M | 97.52M | 104.04M | 107.16M | 110.63M | 125.53M | 125.36M | 127.76M | 129.09M | 139.34M | 133.22M | 127.68M | 126.05M | 126.3M | 123.92M | 114.2M |
Goodwill & Intangibles | 3.91M | 4.03M | 4.11M | 4.19M | 4.3M | 4.42M | 4.5M | 4.61M | 4.72M | 4.83M | 4.94M | 5.05M | 5.16M | 5.27M | 5.38M | 5.5M | 5.61M |
Total Long-Term Assets | 139.95M | 118.63M | 120.04M | 131.05M | 138.39M | 122.87M | 140.29M | 146.15M | 156.43M | 166.27M | 193.52M | 214.74M | 256.17M | 279.04M | 248.65M | 267.6M | 278.04M |
Total Assets | 1.06B | 1.18B | 1.09B | 758.3M | 802.5M | 825.59M | 873.21M | 823.82M | 966.27M | 1.09B | 1.27B | 1.33B | 1.38B | 1.08B | 1.21B | 851.85M | 965.31M |
Account Payables | 84.37M | 96.39M | 75.27M | 99.53M | 94.53M | 94.57M | 121.55M | 122.12M | 124.56M | 101.03M | 86.1M | 74.98M | 70.68M | 59.42M | 76.47M | 44.21M | 54.13M |
Deferred Revenue | 1.19M | 936K | 1.59M | n/a | 1.18M | 1.18M | 4.03M | 4.15M | 10M | n/a | 3.14M | n/a | 265K | 2.6M | 36K | 145K | 254K |
Short-Term Debt | 489.96M | 491.54M | 449.73M | 453.85M | 439.39M | 11.23M | 11.82M | 26.56M | 25.39M | 11.63M | 20.1M | 14.08M | n/a | 7M | n/a | n/a | n/a |
Other Current Liabilities | 308.42M | 317.77M | 310.86M | 268.44M | 242.36M | 36.2M | 31.29M | 20.73M | 26.03M | 12.83M | 10.06M | -8.97M | 3.21M | -3M | 537K | 522K | 627K |
Total Current Liabilities | 885.51M | 907.86M | 838.46M | 848.23M | 798.97M | 197.34M | 212.76M | 192.27M | 198.36M | 171.27M | 142.84M | 115.13M | 95.36M | 100.36M | 116.12M | 70.3M | 72.93M |
Long-Term Debt | 357.31M | 365.08M | 338.93M | 219.05M | 229.63M | 534.25M | 549.48M | 479.37M | 479.99M | 387.56M | 533.14M | 498.13M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 155.07M | 94.3M | 86.39M | 120.72M | 172.16M | 40.6M | 6.64M | 509.9M | 2.96M | n/a | n/a | n/a |
Total Long-Term Liabilities | 365.74M | 377.34M | 352.65M | 231.7M | 241.71M | 773.94M | 733.89M | 566.71M | 600.71M | 655.12M | 679.03M | 603.86M | 609.08M | 100.93M | 95.55M | 94.06M | 89.57M |
Total Liabilities | 1.25B | 1.29B | 1.19B | 1.08B | 1.04B | 971.28M | 946.65M | 758.98M | 799.07M | 826.39M | 821.87M | 718.99M | 704.43M | 201.29M | 211.67M | 164.36M | 162.49M |
Total Debt | 847.27M | 856.62M | 788.66M | 672.64M | 669.01M | 644.26M | 665.84M | 505.94M | 505.38M | 508.38M | 553.24M | 512.21M | 473.66M | 104.96M | 102.3M | 101.01M | 96.48M |
Common Stock | 8.19M | 8.15M | 8.14M | 7.82M | 7.82M | 7.75M | 7.74M | 7.7M | 7.7M | 7.67M | 7.66M | 7.65M | 7.65M | 7.65M | 7.64M | 7.24M | 7.23M |
Retained Earnings | n/a | n/a | -2.55B | -2.47B | -2.39B | -2.28B | -2.21B | -2.06B | -1.96B | -1.86B | -1.79B | -1.62B | -1.55B | -1.41B | -1.31B | -1.23B | -1.09B |
Comprehensive Income | n/a | n/a | 953K | -329.15M | -246M | -153.45M | -81.17M | 57.14M | 159.5M | 255.67M | 443.89M | 3.45M | 665.17M | 875.99M | 985.92M | 680.25M | 795.59M |
Shareholders Equity | -189.81M | -105.71M | -97.32M | -321.13M | -238.18M | -145.7M | -73.43M | 64.84M | 167.2M | 263.35M | 451.55M | 607.84M | 672.82M | 883.63M | 993.56M | 687.49M | 802.82M |
Total Investments | 40.94M | 13.57M | 16.21M | 22.76M | 24.8M | 12.96M | 22.28M | 50.99M | 106.43M | 321.11M | 358.82M | 357.39M | 344.56M | 381.7M | 280.6M | 302.57M | 326.12M |